General Information
Version
4.0
Revision date
2023-02-20
Product name
Superglue MV
supplier name
Soudal N.V
Emergency telephone
+32 70 245 245
Icons in SDS
Company Information
company name
Soudal N.V
e-mail address of the competent person responsible for the Safety Data Sheet
sds@soudal.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
May cause respiratory irritation. Causes skin irritation. Causes serious eye irritation.
2.2 Label elements
Labelling
Hazard pictograms
GHS07
Signal word
Warning
Contains
ethyl 2-cyanoacrylate
Hazard statements
H315 - Causes skin irritation. H319 - Causes serious eye irritation. H335 - May cause respiratory irritation.
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P280 - Wear protective gloves, protective clothing, eye protection, face protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P405 - Store locked up. P501 - Dispose of contents and container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Supplemental label elements
EUH202 - Cyanoacrylate. Danger. Bonds skin and eyes in seconds. Keep out of the reach of children.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component ethyl 2-cyanoacrylate (7085-85-0) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %